CAS 1838651-58-3

2-bromo-N,N-dimethylbenzenesulfonamide

CAS: 1838651-58-3

Fórmula: C₂₂H₁₈F₃N₅O

Pureza: 99%

Forma y color: Solid

Peso molecular: 425.4064

Ref: IN-DA01FW7Z

N-(1-((5-Cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl)-2-(4-(1-(trifluoromethyl)cyclopropyl)phenyl)acetamide

CAS: 1838651-58-3

N-(1-((5-Cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl)-2-(4-(1-(trifluoromethyl)cyclopropyl)phenyl)acetamide

Fórmula: C₂₂H₁₈F₃N₅O

Pureza: 98%

Peso molecular: 425.41

Ref: 54-PC1006498

Apinocaltamide

CAS: 1838651-58-3

Apinocaltamide (ACT-709478) is an orally available and selective T-type calcium channel blocker that cross BBB for Cav3.1, Cav3.2, and Cav3.3,epilepsy.

Fórmula: C₂₂H₁₈F₃N₅O

Pureza: 99.80%

Forma y color: Solid

Peso molecular: 425.41

Ref: TM-T14120

Apinocaltamide

CAS: 1838651-58-3

N-(1-((5-Cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl)-2-(4-(1-(trifluoromethyl)cyclopropyl)phenyl)acetamide

Fórmula: C₂₂H₁₈F₃N₅O

Pureza: 98%

Peso molecular: 425.41

Ref: IN-DG01091429

Apinocaltamide

CAS: 1838651-58-3

Pureza: 95%

Peso molecular: 425.146

Ref: 10-F840847

ACT-709478

CAS: 1838651-58-3

ACT-709478 is an orally bioavailable, non-peptide small molecule for the treatment of epileptic patients. It has a pharmacokinetic half-life of about 4 hours and penetrates the blood–brain barrier. ACT-709478 has been shown to be effective in animal models of cardiovascular diseases. The drug is metabolized by cytochrome P450 enzymes and has functional groups that are not well characterized. The terminal half-life of this molecule is about 2 hours.

Fórmula: C₂₂H₁₈F₃N₅O

Pureza: Min. 95%

Peso molecular: 425.4 g/mol

Ref: 3D-NYC65158